Improved arthropathy scores after use of Extended Half-Life (EHL) products in prophylactic treatment of adult patients with Haemophilia A & B

被引：0
|
作者：
Christidi, Styliani-Despoina [1 ]
Thevaeos, George [1 ]
Zannou, Anna [2 ,3 ]
Vlahopoulou, Dimitra [2 ,3 ]
Veziris, George [1 ]
Gavalaki, Maria [2 ,3 ]
Kourampa, Anna [2 ,3 ]
机构：
[1] Laikon Gen Hosp, Dept Orthoped, Athens, Greece
[2] Blood Transfus Ctr, Athens, Greece
[3] Natl Reference Ctr Congenital Bleeding Disorders, Athens, Greece
来源：
HAEMOPHILIA | 2023年 / 29卷
关键词：
Haemophilia; Extended Half-Life (EHL); HJHS;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PP-WE-040
引用
收藏
页码：38 / 39
页数：2
相关论文
共 50 条
  • [1] IMPROVED ARTHROPATHY SCORES AFTER USE OF EXTENDED HALF LIFE (EHL) PRODUCTS IN PROPHYLACTIC TREATMENT OF ADULT PATIENTS WITH SEVERE HAEMOPHILIA A AND B
    Kouramba, A.
    Thivaios, G.
    George, V.
    Elefterios, K.
    Zygogiannis, K.
    Katsarou, O.
    HAEMOPHILIA, 2020, 26 : 53 - 53
  • [2] Evaluation of treatment and outcome for patients with haemophilia A and haemophilia B on extended half-life (EHL) factor products: A 12-month data analysis
    George, Carly
    Parikh, Sumit
    Carter, Tina
    Mccosker, Joanna
    Carlino, Sara
    Tran, Huyen
    HAEMOPHILIA, 2023, 29 (05) : 1283 - 1290
  • [3] Practical aspects of extended half-life products for the treatment of haemophilia
    Lambert, Thierry
    Benson, Gary
    Dolan, Gerry
    Hermans, Cedric
    Jimenez-Yuste, Victor
    Ljung, Rolf
    Morfini, Massimo
    Zupancic-Salek, Silva
    Santagostino, Elena
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2018, 9 (09) : 295 - 308
  • [4] PERIOPERATIVE USE OF EXTENDED HALF-LIFE (EHL) FVIII AND FIX CONCENTRATES IN CHILDREN WITH HAEMOPHILIA A AND
    Michalopoulou, A.
    Dettoraki, A.
    Margariti, K.
    Stamati, I.
    Politi, D.
    Saslis, S.
    Kapsimali, Z.
    Pergantou, H.
    HAEMOPHILIA, 2022, 28 : 78 - 78
  • [5] Single centre experience of switching from standard half-life to extended half-life products in patients with severe haemophilia A and B
    Phillott, Anica
    Stanley, Jenna
    Alamelu, Jayanthi
    HAEMOPHILIA, 2018, 24 : 32 - 33
  • [6] Real-world outcomes associated with standard half-life and extended half-life factor replacement products for treatment of haemophilia A and B
    Chhabra, Amit
    Spurden, Dean
    Fogarty, Patrick F.
    Tortella, Bartholomew J.
    Rubinstein, Emily
    Harris, Simon
    Pleil, Andreas M.
    Mellor, Jennifer
    de Courcy, Jonathan
    Alvir, Jose
    BLOOD COAGULATION & FIBRINOLYSIS, 2020, 31 (03) : 186 - 192
  • [7] COMPARATIVE ANALYSIS OF PHARMACOKINETIC (PK) STUDY DATA BETWEEN EXTENDED HALF-LIFE (EHL) AND STANDARD HALF-LIFE (SHL) FACTOR PRODUCTS: EXPERIENCE FROM GREEK ADULT HAEMOPHILIA CENTRE
    Christoforou, P.
    Kourampa, A.
    Varaklioti, A.
    Pirpiri, T.
    Balomenou, A.
    Katsarou, O.
    HAEMOPHILIA, 2023, 29 : 61 - 61
  • [8] ENHANCED HALF-LIFE (EHL) VS. STANDARD HALF-LIFE (SHL) REPLACEMENT FACTORS IN HAEMOPHILIA A AND B: APPLICATION OF A HAEMOPHILIA VALUE FRAMEWORK
    Skinner, M.
    Dolan, G.
    Eichler, H.
    O'Mahony, B.
    HAEMOPHILIA, 2021, 27 : 71 - 72
  • [9] Expectations and Concerns Towards New Extended Half-Life (EHL) Products - Results of Surveys Among Haemophilia Patients from the Dach Region
    von Mackensen, Sylvia
    Kalnins, Werner
    Lino, Hostettler
    Joerg, Krucker
    Albisetti, Manuela
    Weiss, Josef
    Pabinger, Ingrid
    Oldenburg, Johannes
    BLOOD, 2016, 128 (22)
  • [10] Scottish experience introducing extended half-life factor concentrates in Haemophilia A and Haemophilia B patients
    Chalmers, Elizabeth
    Bagot, Catherine
    Tait, Robert Campbell
    Anderson, Julia
    Rodgers, Ryan
    Khan, Mohammed
    Watson, Henry
    Craig, Joanne
    Kerr, Ron
    McLaughlin, David
    HAEMOPHILIA, 2018, 24 : 27 - 27
12345